Out of Specification (OOS) Results in Pharmaceutical Quality Control
Understanding Out of Specification (OOS) Results in Pharmaceutical Quality Control Out of Specification: In the pharmaceutical industry, maintaining consistent quality…
Regulatory Pharma Blogs
Understanding Out of Specification (OOS) Results in Pharmaceutical Quality Control Out of Specification: In the pharmaceutical industry, maintaining consistent quality…
Understanding Corrective and Preventive Action (CAPA) in the Pharmaceutical Industry Corrective and Preventive Action (CAPA) is an integral part of…
The Pharmaceutical Quality System (PQS) under EU GMP Guidelines Pharmaceutical Quality System: The European Union (EU) Good Manufacturing Practice (GMP)…
Self-Inspection Under EU GMP Guidelines: A Comprehensive Overview Self-Inspection Under EU GMP Guidelines: The pharmaceutical industry is governed by strict…
SCHEDULE M – GMP – PART 1: GOOD MANUFACTURING PRACTICES FOR PREMISES AND MATERIALS “Schedule M” outlines the guidelines set…
Revised and Expanded Version of Schedule M-II on GMP Guidelines for Cosmetic Manufacturing Introduction to Schedule M-II: Good Manufacturing Practices…
Residue on Ignition / Sulfated Ash Test Methods Residue on Ignition; The Residue on Ignition (RoI), also known as Sulfated…
Quality Control – Overview and Key Principles Quality Control Principles: Quality Control (QC) involves sampling, setting specifications, testing, as well…
Premises and Equipment in EU GMP Guidelines: An In-Depth Overview Premises and Equipment: In the field of pharmaceutical manufacturing, adherence…
Pharmaceutical Glass Containers: An In-Depth Overview of USP General Chapter 660 Pharmaceutical Glass Containers: Pharmaceutical packaging plays a vital role…